Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Clinical trial NCT00233064 · COMPLETED

Trial details

NCT number: NCT00233064
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Lung Disease

Start date: 2005-10-01
Primary completion: 2007-10-01
Enrollment: 417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.